Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00721617 · ClinicalTrials.gov registry record · NA

FFA Hypertension and Inflammation in Lean and Obese Subjects

A NA study of Obesity and Hypertension, sponsored by Emory University.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT00721617: Completed NA study of Obesity and Hypertension, sponsored by Emory University.

NCT00721617 is a NA study of Obesity and Hypertension that has completed, run by Emory University. The registered enrollment target is 12 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00721617, a NA study of Obesity and Hypertension, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Although a large number of obese patients develop high blood pressure, the cause is unknown. The purpose of this study is to look at the effect of high fatty acids (a type of fat) in the development of high blood pressure in obese people.

Primary Outcome

Endothelium-dependent brachial artery flow-mediated dilation (FMD) was assessed. Ultrasound images of the brachial artery were obtained and arterial diameters were measured with customized software. FMD is expressed as the change in diameter from baseline to 4 hours.

Interventions

  • OTHER Normal Saline
  • OTHER Intralipid 20%
  • OTHER Oral fat load

Study Locations (1)

Georgia

  • Grady Memorial Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2009-04
Est. Completion 2011-06
Phase NA
Emory University

1,208 total trials

What the finished NCT00721617 record still lists

NCT00721617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Normal Saline is the first listed.

NCT00721617 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT00721617 about?

NCT00721617 is a clinical study titled "FFA Hypertension and Inflammation in Lean and Obese Subjects". Although a large number of obese patients develop high blood pressure, the cause is unknown. The purpose of this study is to look at the effect of high fatty acids (a type of fat) in the development of high blood pressure in obese people.

What is the current status of trial NCT00721617?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-04. Estimated completion is 2011-06.

What conditions does trial NCT00721617 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Diabetes.

What interventions are being tested in trial NCT00721617?

The interventions under investigation include: Normal Saline (OTHER), Intralipid 20% (OTHER), Oral fat load (OTHER).

Who is sponsoring clinical trial NCT00721617?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00721617 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00721617's enrollment target sits among peer trials

12 1015th of 1053 higher than 30 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00721617, the US trial registry maintained by the National Library of Medicine. NCT00721617 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.